Verastem reported $5.93M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.06B 110M
AstraZeneca AZN:LN 3.06B 1.03B
Curis CRIS:US $ 5.67M 900K
Cytokinetics CYTK:US $ 33.07M 736K
Epizyme EPZM:US $ 27.2M 3.66M
Gilead Sciences GILD:US $ 1.08B 567M
Immunogen IMGN:US $ 16.65M 3.07M
Laboratory Of America LH:US $ 464.1M 61.7M
Novartis NOVN:VX 3.5B 486M
Tg Therapeutics TGTX:US $ 20.61M 11.8M
Verastem VSTM:US $ 5.93M 274K
YTE INCY:US $ 209.58M 16.62M
Ziopharm Oncology ZIOP:US $ 3.5M 1.41M